Elevated serum level of growth arrest-specific protein 6 (Gas6) in systemic lupus erythematosus patients is associated with nephritis and cutaneous vasculitis

Rheumatology International

Volumn 34, Issue 5, 2014, Pages 625-629

  Wu, Chien Sheng ^a,b   Hu, Chung Yi ^b,c   Tsai, Hwei Fang ^d,e   Chyuan, I Tsu ^b   Chan, Cheng Ju ^c   Chang, Sheng Kai ^c   Hsu, Ping Ning ^b,c  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Growth arrest specific protein 6 (Gas6); Nephritis; Systemic lupus erythematosus; Vasculitis

Indexed keywords

GROWTH ARREST SPECIFIC PROTEIN 6; BIOLOGICAL MARKER; GROWTH ARREST-SPECIFIC PROTEIN 6; SIGNAL PEPTIDE;

ADULT; AGE; ALOPECIA; ARTHRITIS; ARTICLE; CONTROLLED STUDY; CUTANEOUS VASCULITIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; FEVER; HUMAN; LEUKOPENIA; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MOUTH ULCER; MYOSITIS; NEPHRITIS; PERICARDITIS; PLEURISY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; VASCULITIS; BLOOD; CASE CONTROL STUDY; DISEASE COURSE; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MIDDLE AGED; PROGNOSIS; UPREGULATION;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; PROGNOSIS; UP-REGULATION; VASCULITIS;

EID: 84901341505     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-013-2882-1     Document Type: Article

References (22)

1. Nagata K, Ohashi K, Nakano T, Arita H, Zong C, Hanafusa H, Mizuno K (1996) Identification of the product of growth arrest-specific gene 6 as a common ligand for Axl, Sky, and Mer receptor tyrosine kinases. J Biol Chem 271:30022-30027 (Pubitemid 26389640)
2. Alciato F, Sainaghi PP, Sola D, Castello L, Avanzi GC (2010) TNF-alpha, IL-6, and IL-1 expression is inhibited by GAS6 in monocytes/macrophages. J Leukoc Biol 87:869-875
3. Gould WR, Baxi SM, Schroeder R, Peng YW, Leadley RJ, Peterson JT, Perrin LA (2005) Gas6 receptors Axl, Sky and Mer enhance platelet activation and regulate thrombotic responses. J Thromb Haemost 3:733-741 (Pubitemid 41647888)
4. Tjwa M, Bellido-Martin L, Lin Y, Lutgens E, Plaisance S, Bono F, Delesque-Touchard N, Herve C, Moura R, Billiau AD, Aparicio C, Levi M, Daemen M, Dewerchin M, Lupu F, Arnout J, Herbert JM, Waer M, de Garcia FP, Dahlback B, Carmeliet P, Hoylaerts MF, Moons L (2008) Gas6 promotes inflammation by enhancing interactions between endothelial cells, platelets, and leukocytes. Blood 111:4096-4105
5. Wu CS, Hu CY, Chan CJ, Chang SK, Hsu PN (2012) Genetic polymorphism of the growth arrest-specific 6 gene is associated with cutaneous vasculitis in Taiwanese patients with systemic lupus erythematosus. Clin Rheumatol 31:1443-1448
6. Chiu YM, Lai CH (2010) Nationwide population-based epidemiologic study of systemic lupus erythematosus in Taiwan. Lupus 19:1250-1255
7. Ekman C, Jonsen A, Sturfelt G, Bengtsson A, Dahlback B (2011) Plasma concentrations of Gas6 and sAxl correlate with disease activity in systemic lupus erythematosus. Rheumatology (Oxford) 50:1064-1069
8. Kim HA, Nam JY, Jeon JY, An JM, Jung JY, Bae CB, Suh CH (2013) Serum growth arrest-specific protein 6 levels are a reliable biomarker of disease activity in systemic lupus erythematosus. J Clin Immunol 33:143-150
9. Recarte-Pelz P, Tassies D, Espinosa G, Hurtado B, Sala N, Cervera R, Reverter JC, de Frutos PG (2013) Vitamin K-dependent proteins GAS6 and protein S and TAM receptors in patients of systemic lupus erythematosus: correlation with common genetic variants and disease activity. Arthritis Res Ther 15:R41
10. Suh CH, Hilliard B, Li S, Merrill JT, Cohen PL (2010) TAM receptor ligands in lupus: protein S but not Gas6 levels reflect disease activity in systemic lupus erythematosus. Arthritis Res Ther 12:R146
11. Gheita TA, Bassyouni IH, Bassyouni RH (2012) Plasma concentrations of growth arrest specific protein 6 and the soluble form of its tyrosine kinase receptor Axl in patients with systemic lupus erythematosus and Behcets disease. J Clin Immunol 32:1279-1286
12. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277 (Pubitemid 13221242)
13. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725
14. Gladman DD, Ibanez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29:288-291 (Pubitemid 34118775)
15. Alciato F, Sainaghi PP, Castello L, Bergamasco L, Carnieletto S, Avanzi GC (2008) Development and validation of an ELISA method for detection of growth arrest specific 6 (GAS6) protein in human plasma. J Immunoassay Immunochem 29:167-180 (Pubitemid 351431254)
16. Munoz X, Obach V, Hurtado B, de Frutos PG, Chamorro A, Sala N (2007) Association of specific haplotypes of GAS6 gene with stroke. Thromb Haemost 98:406-412 (Pubitemid 47250244)
17. Munoz X, Sumoy L, Ramirez-Lorca R, Villar J, de Frutos PG, Sala N (2004) Human vitamin K-dependent GAS6: gene structure, allelic variation, and association with stroke. Hum Mutat 23:506-512 (Pubitemid 38569224)
18. Jiang L, Liu CY, Yang QF, Wang P, Zhang W (2009) Plasma level of growth arrest-specific 6 (GAS6) protein and genetic variations in the GAS6 gene in patients with acute coronary syndrome. Am J Clin Pathol 131:738-743
19. Fiebeler A, Park JK, Muller DN, Lindschau C, Mengel M, Merkel S, Banas B, Luft FC, Haller H (2004) Growth arrest specific protein 6/Axl signaling in human inflammatory renal diseases. Am J Kidney Dis 43:286-295 (Pubitemid 38146327)
20. Nagai K, Arai H, Yanagita M, Matsubara T, Kanamori H, Nakano T, Iehara N, Fukatsu A, Kita T, Doi T (2003) Growth arrest-specific gene 6 is involved in glomerular hypertrophy in the early stage of diabetic nephropathy. J Biol Chem 278:18229-18234 (Pubitemid 36799440)
21. Nagai K, Matsubara T, Mima A, Sumi E, Kanamori H, Iehara N, Fukatsu A, Yanagita M, Nakano T, Ishimoto Y, Kita T, Doi T, Arai H (2005) Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy. Kidney Int 68:552-561 (Pubitemid 43323110)
22. Yanagita M (2004) Gas6, warfarin, and kidney diseases. Clin Exp Nephrol 8:304-309